These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 28464373)
1. Is it time to improve colorectal cancer surveillance from 'one size fits all' to personalized care planning? Di Fabio F; Moran B Colorectal Dis; 2017 Jun; 19(6):525-527. PubMed ID: 28464373 [No Abstract] [Full Text] [Related]
2. Integrating personalised genomics into risk stratification models of population screening for colorectal cancer. Cenin D; O'Leary P; Lansdorp-Vogelaar I; Preen D; Jenkins M; Moses E Aust N Z J Public Health; 2017 Feb; 41(1):3-4. PubMed ID: 27774701 [No Abstract] [Full Text] [Related]
4. White light endoscopy versus chromoendoscopy for the detection of dysplasia during inflammatory bowel disease surveillance with colonoscopy. Vaziri H; Anderson JC Gastroenterology; 2015 Nov; 149(6):1630-2. PubMed ID: 26428464 [No Abstract] [Full Text] [Related]
5. Advances in CRC Prevention: Screening and Surveillance. Dekker E; Rex DK Gastroenterology; 2018 May; 154(7):1970-1984. PubMed ID: 29454795 [TBL] [Abstract][Full Text] [Related]
6. American Cancer Society updates its colorectal cancer screening guideline: New recommendation is to start screening at age 45 years. Cancer; 2018 Sep; 124(18):3631-3632. PubMed ID: 30387885 [No Abstract] [Full Text] [Related]
9. Population-Based Precision Cancer Screening-Letter. Olsen KS; Lund E Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):975. PubMed ID: 28506964 [No Abstract] [Full Text] [Related]
10. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview. Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771 [TBL] [Abstract][Full Text] [Related]
12. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial. Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385 [TBL] [Abstract][Full Text] [Related]
13. Patients with 'interval' colorectal cancers have worse outcomes compared with cancers in patients who decline the National Bowel Cancer Screening Programme - Results from a Multicentre Study. George AT; Field A Colorectal Dis; 2017 Jun; 19(6):590-591. PubMed ID: 28494513 [No Abstract] [Full Text] [Related]
14. Colorectal Cancer Screening Challenges in West Virginia. W V Med J; 2015; 111(6):12-3. PubMed ID: 26665890 [No Abstract] [Full Text] [Related]
15. Screening for cancer. von Knebel Doeberitz M Int J Cancer; 2010 Mar; 126(5):1037-8. PubMed ID: 20039333 [No Abstract] [Full Text] [Related]
16. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer. Corbo C; Cevenini A; Salvatore F Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089 [TBL] [Abstract][Full Text] [Related]
18. Colorectal Cancer Screening Modalities: Variable Uptake, Variable Yield. Barry HC Am Fam Physician; 2016 Jun; 93(12):1032-6. PubMed ID: 27304774 [No Abstract] [Full Text] [Related]
19. Screening, surveillance, and prevention of colorectal cancer. Lieberman D Gastrointest Endosc Clin N Am; 2008 Jul; 18(3):595-605, xi. PubMed ID: 18674706 [TBL] [Abstract][Full Text] [Related]
20. [Necessity and feasibility of screening for colorectal cancer in China]. Zhang SZ Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]